Previous Article | Next Article 
Journal of Virology, September 1998, p. 7221-7227, Vol. 72, No. 9
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Heparin-Like Structures on Respiratory Syncytial
Virus Are Involved in Its Infectivity In Vitro
C.
Bourgeois,1,*
J. B.
Bour,1
K.
Lidholt,2
C.
Gauthray,1 and
P.
Pothier1
Laboratoire de Microbiologie Médicale
et Moléculaire, Faculté de Médecine, 21033 Dijon
Cedex, France,1 and
Department of
Medical and Physiological Chemistry, The Biomedical Center, University
of Uppsala, S-75 123 Uppsala, Sweden2
Received 12 January 1998/Accepted 5 June 1998
Addition of heparin to the virus culture inhibited syncytial plaque
formation due to respiratory syncytial virus (RSV). Moreover, pretreatment of the virus with heparinase or an inhibitor of heparin, protamine, greatly reduced virus infectivity. Two anti-heparan sulfate
antibodies stained RSV-infected cells, but not noninfected cells, by
immunofluorescence. One of the antibodies was capable of neutralizing
RSV infection in vitro. These results prove that heparin-like
structures identified on RSV play a major role in early stages of
infection. The RSV G protein is the attachment protein. Both
anti-heparan sulfate antibodies specifically bound to this protein.
Enzymatic digestion of polysaccharides in the G protein reduced the
binding, which indicates that heparin-like structures are on the G
protein. Such oligosaccharides may therefore participate in the
attachment of the virus.
*
Corresponding author. Mailing address: Laboratoire de
Microbiologie Médicale et Moléculaire, Faculté de
Médecine, 7 Bld. Jeanne d'Arc, 21033 Dijon Cedex, France. Phone:
33 3 80 29 38 56. Fax: 33 3 80 29 36 04. E-mail:
Pierre.Pothier{at}u-bourgogne.fr.
Journal of Virology, September 1998, p. 7221-7227, Vol. 72, No. 9
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Crim, R. L., Audet, S. A., Feldman, S. A., Mostowski, H. S., Beeler, J. A.
(2007). Identification of Linear Heparin-Binding Peptides Derived from Human Respiratory Syncytial Virus Fusion Glycoprotein That Inhibit Infectivity. J. Virol.
81: 261-271
[Abstract]
[Full Text]
-
Herd, K. A., Mahalingam, S., Mackay, I. M., Nissen, M., Sloots, T. P., Tindle, R. W.
(2006). Cytotoxic T-Lymphocyte Epitope Vaccination Protects against Human Metapneumovirus Infection and Disease in Mice. J. Virol.
80: 2034-2044
[Abstract]
[Full Text]
-
Elliott, M. B., Pryharski, K. S., Yu, Q., Parks, C. L., Laughlin, T. S., Gupta, C. K., Lerch, R. A., Randolph, V. B., LaPierre, N. A., Dack, K. M. H., Hancock, G. E.
(2004). Recombinant Respiratory Syncytial Viruses Lacking the C-Terminal Third of the Attachment (G) Protein Are Immunogenic and Attenuated In Vivo and In Vitro. J. Virol.
78: 5773-5783
[Abstract]
[Full Text]
-
Budge, P. J., Li, Y., Beeler, J. A., Graham, B. S.
(2004). RhoA-Derived Peptide Dimers Share Mechanistic Properties with Other Polyanionic Inhibitors of Respiratory Syncytial Virus (RSV), Including Disruption of Viral Attachment and Dependence on RSV G. J. Virol.
78: 5015-5022
[Abstract]
[Full Text]
-
Budge, P. J., Lebowitz, J., Graham, B. S.
(2003). Antiviral Activity of RhoA-Derived Peptides against Respiratory Syncytial Virus Is Dependent on Formation of Peptide Dimers. Antimicrob. Agents Chemother.
47: 3470-3477
[Abstract]
[Full Text]
-
Douglas, J. L., Panis, M. L., Ho, E., Lin, K.-Y., Krawczyk, S. H., Grant, D. M., Cai, R., Swaminathan, S., Cihlar, T.
(2003). Inhibition of Respiratory Syncytial Virus Fusion by the Small Molecule VP-14637 via Specific Interactions with F Protein. J. Virol.
77: 5054-5064
[Abstract]
[Full Text]
-
Schlender, J., Zimmer, G., Herrler, G., Conzelmann, K.-K.
(2003). Respiratory Syncytial Virus (RSV) Fusion Protein Subunit F2, Not Attachment Protein G, Determines the Specificity of RSV Infection. J. Virol.
77: 4609-4616
[Abstract]
[Full Text]
-
Teng, M. N., Collins, P. L.
(2002). The Central Conserved Cystine Noose of the Attachment G Protein of Human Respiratory Syncytial Virus Is Not Required for Efficient Viral Infection In Vitro or In Vivo. J. Virol.
76: 6164-6171
[Abstract]
[Full Text]
-
Schlender, J., Walliser, G., Fricke, J., Conzelmann, K.-K.
(2002). Respiratory Syncytial Virus Fusion Protein Mediates Inhibition of Mitogen-Induced T-Cell Proliferation by Contact. J. Virol.
76: 1163-1170
[Abstract]
[Full Text]
-
Techaarpornkul, S., Barretto, N., Peeples, M. E.
(2001). Functional Analysis of Recombinant Respiratory Syncytial Virus Deletion Mutants Lacking the Small Hydrophobic and/or Attachment Glycoprotein Gene. J. Virol.
75: 6825-6834
[Abstract]
[Full Text]
-
Goodfellow, I. G., Sioofy, A. B., Powell, R. M., Evans, D. J.
(2001). Echoviruses Bind Heparan Sulfate at the Cell Surface. J. Virol.
75: 4918-4921
[Abstract]
[Full Text]
-
Hallak, L. K., Spillmann, D., Collins, P. L., Peeples, M. E.
(2000). Glycosaminoglycan Sulfation Requirements for Respiratory Syncytial Virus Infection. J. Virol.
74: 10508-10513
[Abstract]
[Full Text]
-
Martínez, I., Melero, J. A.
(2000). Binding of human respiratory syncytial virus to cells: implication of sulfated cell surface proteoglycans. J. Gen. Virol.
81: 2715-2722
[Abstract]
[Full Text]
-
Feldman, S. A., Hendry, R. M., Beeler, J. A.
(1999). Identification of a Linear Heparin Binding Domain for Human Respiratory Syncytial Virus Attachment Glycoprotein G. J. Virol.
73: 6610-6617
[Abstract]
[Full Text]